Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Downgrades Dicerna Pharmaceuticals to Market Perform

Cowen & Co. analyst Yaron Werber downgrades Dicerna Pharmaceuticals (NASDAQ:DRNA) from Outperform to Market Perform.
byBenzinga Newsdesk
August 6, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cowen & Co. analyst Yaron Werber downgrades Dicerna Pharmaceuticals (NASDAQ:DRNA) from Outperform to Market Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0